TY - JOUR
T1 - Impact of Treatment for Nasal Cavity Disorders on Sleep Quality
T2 - Systematic Review and Meta-analysis
AU - Fried, Jacob
AU - Yuen, Erick
AU - Zhang, Kathy
AU - Li, Andraia
AU - Rowan, Nicholas R.
AU - Schlosser, Rodney J.
AU - Nguyen, Shaun A.
AU - Gudis, David A.
N1 - Publisher Copyright:
© American Academy of Otolaryngology–Head and Neck Surgery Foundation 2021.
PY - 2022/4
Y1 - 2022/4
N2 - Objective: To determine the impact of treatment for patients with nasal obstruction secondary to allergic rhinitis (AR) and nasal septal deviation (NSD) on sleep quality. Data Sources: Primary studies were identified though PubMed, Scopus, Cochrane Library, and Web of Science. Review Methods: A systematic review was performed by querying databases for articles published through August 2020. Studies were included that reported on objective sleep parameters (apnea-hypopnea index) and sinonasal and sleep-specific patient-reported outcome measures: Rhinoconjunctivitis Quality of Life Questionnaire, Nasal Obstruction Symptom Evaluation, Epworth Sleepiness Scale (EpSS), and Pittsburgh Sleep Quality Index (PSQI). Results: The database search yielded 1414 unique articles, of which 28 AR and 7 NSD studies were utilized for meta-analysis. A total of 9037 patients (8515 with AR, 522 with NSD) were identified with a mean age of 35.0 years (35.3 for AR, 34.0 for NSD). Treatment for AR and NSD significantly improved subjective sleep quality. For AR, the EpSS mean difference was −1.5 (95% CI, –2.4 to –0.5; P =.002) and for the PSQI, –1.7 (95% CI, –2.1 to –1.2; P <.00001). For NSD, the EpSS mean difference was −3.2 (95% CI, –4.2 to –2.2; P <.00001) and for the PSQI, –3.4 (95% CI, –6.1 to –0.6; P =.02). Conclusion: Subjective sleep quality significantly improved following treatment for AR and NSD. There were insufficient data to demonstrate that objective metrics of sleep quality similarly improved.
AB - Objective: To determine the impact of treatment for patients with nasal obstruction secondary to allergic rhinitis (AR) and nasal septal deviation (NSD) on sleep quality. Data Sources: Primary studies were identified though PubMed, Scopus, Cochrane Library, and Web of Science. Review Methods: A systematic review was performed by querying databases for articles published through August 2020. Studies were included that reported on objective sleep parameters (apnea-hypopnea index) and sinonasal and sleep-specific patient-reported outcome measures: Rhinoconjunctivitis Quality of Life Questionnaire, Nasal Obstruction Symptom Evaluation, Epworth Sleepiness Scale (EpSS), and Pittsburgh Sleep Quality Index (PSQI). Results: The database search yielded 1414 unique articles, of which 28 AR and 7 NSD studies were utilized for meta-analysis. A total of 9037 patients (8515 with AR, 522 with NSD) were identified with a mean age of 35.0 years (35.3 for AR, 34.0 for NSD). Treatment for AR and NSD significantly improved subjective sleep quality. For AR, the EpSS mean difference was −1.5 (95% CI, –2.4 to –0.5; P =.002) and for the PSQI, –1.7 (95% CI, –2.1 to –1.2; P <.00001). For NSD, the EpSS mean difference was −3.2 (95% CI, –4.2 to –2.2; P <.00001) and for the PSQI, –3.4 (95% CI, –6.1 to –0.6; P =.02). Conclusion: Subjective sleep quality significantly improved following treatment for AR and NSD. There were insufficient data to demonstrate that objective metrics of sleep quality similarly improved.
KW - allergic rhinitis
KW - meta-analysis
KW - nasal obstruction
KW - nose diseases
KW - sleep
UR - http://www.scopus.com/inward/record.url?scp=85110128743&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85110128743&partnerID=8YFLogxK
U2 - 10.1177/01945998211029527
DO - 10.1177/01945998211029527
M3 - Review article
C2 - 34253107
AN - SCOPUS:85110128743
SN - 0194-5998
VL - 166
SP - 633
EP - 642
JO - Otolaryngology - Head and Neck Surgery (United States)
JF - Otolaryngology - Head and Neck Surgery (United States)
IS - 4
ER -